Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 16, 2022
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
Silvan Tuerkcan Maintained (VOR) at Buy with Decreased Target to $30 on, Mar 16th, 2022
Silvan Tuerkcan of JMP Securities, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $40 to $30 on, Mar 16th, 2022.
Silvan has made no other calls on VOR in the last 4 months.
There are 3 other peers that have a rating on VOR. Out of the 3 peers that are also analyzing VOR, 0 agree with Silvan's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Silvan
- Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $26 on, Friday, December 17th, 2021
- Jack Allen of "Baird" Initiated at Buy and Held Target at $38 on, Friday, December 3rd, 2021
- Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $30 on, Thursday, December 2nd, 2021
